Because lispro insulin was the first analog investigated, there are a number of studies in patients with CKD [140–142] showing it has a beneficial effect in reducing glomerular hyperfiltration and renal effects of hyperglycemia triggered by meals; these effects are possibly related to an antagonistic effect on insulin-like growth factor-1 [140]. Here, INS is linked to Hyperglycemia.